Clinical Trial Update: The Safety and Preliminary Tolerability of Lyophilized Lucinactant in Adults With Coronavirus Disease 2019 (COVID-19) [Phase 2]

View source ↗

Summary

Phase 2 trial assessing safety and preliminary tolerability of lyophilized lucinactant in adults with COVID-19-related acute lung injury/ARDS; study completed w…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Injury
• Respiratory Distress Syndrome

Drugs mentioned

• lucinactant (lyophilized) (lucinactant)

Snippet

Sponsor: Windtree Therapeutics | Conditions: COVID-19, Acute Lung Injury/Acute Respiratory Distress Syndrome (ARDS) | Phase 2 | Status: COMPLETED | Results posted: 2023-06-23